196 related articles for article (PubMed ID: 12239214)
1. Transcriptional activity among high and low risk human papillomavirus E2 proteins correlates with E2 DNA binding.
Hou SY; Wu SY; Chiang CM
J Biol Chem; 2002 Nov; 277(47):45619-29. PubMed ID: 12239214
[TBL] [Abstract][Full Text] [Related]
2. trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors.
Ushikai M; Lace MJ; Yamakawa Y; Kono M; Anson J; Ishiji T; Parkkinen S; Wicker N; Valentine ME; Davidson I
J Virol; 1994 Oct; 68(10):6655-66. PubMed ID: 8083999
[TBL] [Abstract][Full Text] [Related]
3. Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines.
Goodwin EC; Naeger LK; Breiding DE; Androphy EJ; DiMaio D
J Virol; 1998 May; 72(5):3925-34. PubMed ID: 9557678
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes.
Bouvard V; Storey A; Pim D; Banks L
EMBO J; 1994 Nov; 13(22):5451-9. PubMed ID: 7957111
[TBL] [Abstract][Full Text] [Related]
5. Enhanced transcriptional activation by E2 proteins from the oncogenic human papillomaviruses.
Kovelman R; Bilter GK; Glezer E; Tsou AY; Barbosa MS
J Virol; 1996 Nov; 70(11):7549-60. PubMed ID: 8892874
[TBL] [Abstract][Full Text] [Related]
6. The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex.
Dostatni N; Lambert PF; Sousa R; Ham J; Howley PM; Yaniv M
Genes Dev; 1991 Sep; 5(9):1657-71. PubMed ID: 1653173
[TBL] [Abstract][Full Text] [Related]
7. The E2 trans-activator can act as a repressor by interfering with a cellular transcription factor.
Stenlund A; Botchan MR
Genes Dev; 1990 Jan; 4(1):123-36. PubMed ID: 2155158
[TBL] [Abstract][Full Text] [Related]
8. DNA structure and flexibility in the sequence-specific binding of papillomavirus E2 proteins.
Hines CS; Meghoo C; Shetty S; Biburger M; Brenowitz M; Hegde RS
J Mol Biol; 1998 Mar; 276(4):809-18. PubMed ID: 9500925
[TBL] [Abstract][Full Text] [Related]
9. The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31.
Stubenrauch F; Zobel T; Iftner T
J Virol; 2001 May; 75(9):4139-49. PubMed ID: 11287563
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.
Dong G; Broker TR; Chow LT
J Virol; 1994 Feb; 68(2):1115-27. PubMed ID: 8289341
[TBL] [Abstract][Full Text] [Related]
11. Binding of the human papillomavirus type 16 p97 promoter by the adeno-associated virus Rep78 major regulatory protein correlates with inhibition.
Zhan D; Santin AD; Liu Y; Parham GP; Li C; Meyers C; Hermonat PL
J Biol Chem; 1999 Oct; 274(44):31619-24. PubMed ID: 10531369
[TBL] [Abstract][Full Text] [Related]
12. Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex.
Hou SY; Wu SY; Zhou T; Thomas MC; Chiang CM
Mol Cell Biol; 2000 Jan; 20(1):113-25. PubMed ID: 10594014
[TBL] [Abstract][Full Text] [Related]
13. Competitive binding of viral E2 protein and mammalian core-binding factor to transcriptional control sequences of human papillomavirus type 8 and bovine papillomavirus type 1.
Schmidt HM; Steger G; Pfister H
J Virol; 1997 Oct; 71(10):8029-34. PubMed ID: 9311900
[TBL] [Abstract][Full Text] [Related]
14. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
15. E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain.
McBride AA; Byrne JC; Howley PM
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):510-4. PubMed ID: 2536165
[TBL] [Abstract][Full Text] [Related]
16. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element.
Tan SH; Gloss B; Bernard HU
Nucleic Acids Res; 1992 Jan; 20(2):251-6. PubMed ID: 1311070
[TBL] [Abstract][Full Text] [Related]
17. Early promoters of genital and cutaneous human papillomaviruses are differentially regulated by the bovine papillomavirus type 1 E2 gene product.
Guido MC; Zamorano R; Garrido-Guerrero E; Gariglio P; García-Carrancá A
J Gen Virol; 1992 Jun; 73 ( Pt 6)():1395-400. PubMed ID: 1318941
[TBL] [Abstract][Full Text] [Related]
18. A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein.
Vance KW; Campo MS; Morgan IM
J Virol; 2001 Mar; 75(6):2829-38. PubMed ID: 11222708
[TBL] [Abstract][Full Text] [Related]
19. Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions.
Garrido-Guerrero E; Carrillo E; Guido M; Zamorano R; García-Carranca A; Gariglio P
Arch Med Res; 1996; 27(3):389-94. PubMed ID: 8854400
[TBL] [Abstract][Full Text] [Related]
20. An enhanced epithelial response of a papillomavirus promoter to transcriptional activators.
Vance KW; Campo MS; Morgan IM
J Biol Chem; 1999 Sep; 274(39):27839-44. PubMed ID: 10488130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
